The PE Ratio as of December 2025 (TTM) for GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) is 45.05

According to GlaxoSmithKline Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is 45.05. This represents a change of -10.03% compared to the average of 50.07 of the last 4 quarters.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) Historical PE Ratio (quarterly & annually)

How has GLAXO.NS PE Ratio performed in the past?

The mean historical PE Ratio of GlaxoSmithKline Pharmaceuticals Limited over the last ten years is 71.45. The current 45.05 PE Ratio has changed 6.20% with respect to the historical average. Over the past ten years (40 quarters), GLAXO.NS's PE Ratio was at its highest in in the March 2021 quarter at 478.40. The PE Ratio was at its lowest in in the December 2019 quarter at -10.31.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of GlaxoSmithKline Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) Average PE Ratio

How has GLAXO.NS PE Ratio performed in the past?

The current PE Ratio of GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) PE Ratio vs. Peers

How is GLAXO.NS’s PE Ratio compared to its peers?

GlaxoSmithKline Pharmaceuticals Limited’s PE Ratio is greater than Gland Pharma Limited (36.51), greater than Gland Pharma Limited (36.51), greater than Abbott India Limited (40.76), greater than Abbott India Limited (40.76), less than Laurus Labs Limited (80.99), less than Laurus Labs Limited (80.99), less than Glenmark Pharmaceuticals Limited (73.73), less than Glenmark Pharmaceuticals Limited (73.73), greater than Ipca Laboratories Limited (44.50), greater than Ipca Laboratories Limited (44.50),

Build a custom stock screener for GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GlaxoSmithKline Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GlaxoSmithKline Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.